CAVE CREEK, Ariz., Aug. 12, 2013 /PRNewswire/ -- Endexx
Corporation OTC: EDXC. Endexx, through its wholly owned
subsidiary, Dispense Labs LLC., has secured its "Supply Agreement"
and its Intellectual Property "Licensing Agreement" with AutoCrib
Inc. This agreement ensures International Exclusive rights for the
Autospense™ tracking, inventory control, dispensing technology
platform for the Marijuana and Cannabis industries. The AutoCrib
1000™, in Joint Collaboration between AutoCrib Inc. and Dispense
Labs LLC. was specifically adapted and designed as a pharmaceutical
grade dispense system for both the medical marijuana and
recreational markets, as well as, edibles, concentrates, delivery
systems, tobacco products, vaporizers, electronic cigarettes and
other related products. These agreements solidify a long term
and secure business partnership between Endexx Corporation's,
Dispense Labs LLC., and AutoCrib Inc.
The Autospense™ system provides the capability to dispense
a wide variety of objects or packages. Depending on their size,
Autospense™ can manage approximately 800- 1000 individual packaged
items for dispensing. The system also accepts US currency,
credit and debit cards, and stored value devices. Autospense™
provides a complete user interface platform allowing
patients/customers to visually select their chosen items, by price,
brand, use and quantity. A full photo library and descriptions of
each item assists a patient/customer in purchasing exactly what
they need or prefer through an interactive touch screen. The system
also provides patient/member verification tools, i.e., biometric
fingerprinting, providing protection for the dispensary, retail
outlet or health clinic dispensing cannabis related
products. Endexx, through Dispense Labs LLC., is now planning,
designing and securing access to external technologies and services
for a complete enterprise suite platform that enhances the seed to
sale tracking, transaction, accountability and compliance solutions
for the rapidly growing marijuana industry.
The Autospense™ solution can be implemented at every point in
the supply chain of the marijuana plant: seed, grower, harvest,
processing, testing, transportation, pain clinic, alternative
medicine facilities, dispensing, inventory control, law
enforcement, compliance, Doctors, caregivers, patient possession
and the sale. This total solution technology protects the
patient/customer and ensures a safe and compliant product. The
technology provides a full compliance package for all handlers of
the product from seed to sale. Through standardization, Endexx,
Dispense Labs, and the M3Hub will foster and nurture a sustainable
growth industry.
About Endexx:
Endexx Corporation is a micro-cap publicly traded company,
representing the interest of its shareholders and collaborating
with independent software developers, scientists, engineers, and
other companies to build businesses that can thrive collectively in
the equity markets. Endexx's team recognizes that individually
small companies with new technologies have an extremely difficult
time sustaining themselves as stand-alone companies. Through our
collaborative practices, individual and group skill sets are better
utilized to develop technology and grow the business, while
centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at
minimum 10-50 years of experience in their respective fields. The
business professionals associated with the direction of the company
all have experience growing businesses, developing and implementing
new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a
platform for entrepreneurs to thrive, offering maximum return on
investment through equity ownership in the parent corporation. Each
individual is a shareholder and is encouraged and self-driven to be
successful and contribute to the overall objective of increasing
shareholder value.
About Dispense Labs
Dispense Labs LLC., has spent several years investing in the
research, design and development, and beta testing of Autospense™,
a one-of-a-kind technologically driven smart system that allows for
the automated dispensing of medical marijuana along with precise
inventory control, utilizing predictive analytic algorithm and
tracking software.
Autospense™ is a uniquely designed, high-tech automated
dispensing system that exceeds industry standards. The software
used is specifically designed to properly control transactions and
manage inventory. This will significantly improve profitability,
accountability, security tracking and customer satisfaction.
The Autospense™ solution can easily be integrated with external
software and service solutions as well, allowing for other market
alliances and business partners to utilize this core technology to
support other industry related ancillary services. The Autospense™
system is the only total technology solution in the medical
marijuana industry today.
Contact: Todd Davis at
Todd.Davis@endexx.com
Contact Endexx via email to receive corporate news and updates
at Endexx@endexx.com
http://www.otcmarkets.com/stock/EDXC/quote, www.endexx.com,
www.autospense.com
Safe Harbor Statement
This press release contains forward-looking information within
the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), including statements regarding
potential sales, the success of the company's business, as well as
statements that include the word "believe" or similar expressions.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of Endexx to differ materially from
those implied or expressed by such forward-looking statements. This
press release speaks as of the date first set forth above, and
Endexx assumes no responsibility to update the information included
herein for events occurring after the date hereof. Actual results
could differ materially from those anticipated due to factors such
as the lack of capital, timely development of products, inability
to deliver products when ordered, inability of potential customer
to pay for ordered products, and political and economic risks
inherent in international trade.
SOURCE Endexx Corporation